prices increase butquality of care does not. A health-care company that controls many aspects of patient care couldraise prices for rivals wishing to access its network. Some also worry about physicians being nudged towards offering the cheapest ...
which is known to increase the risk of cleft palate in mothers who take the drug while pregnant. REMS seems like a great way to keep Qnexa out of the hands of pregnant women, similar toRevlimid(which has an incredibly onerous REMS). Lorquess has the FDA concerned ...